• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Extrapolating the speed of psoriasis clearance: A comparative analysis of biologic agents in clinical trials.

作者信息

Pfau Creighton, Lovell Katie K, Feldman Steven R

机构信息

Department of Dermatology, Center for Dermatology Research, Wake Forest University School of Medicine, Winston-Salem, North Carolina.

Department of Dermatology, Center for Dermatology Research, Wake Forest University School of Medicine, Winston-Salem, North Carolina.

出版信息

J Am Acad Dermatol. 2024 Dec;91(6):1223-1224. doi: 10.1016/j.jaad.2024.06.103. Epub 2024 Aug 19.

DOI:10.1016/j.jaad.2024.06.103
PMID:39168306
Abstract
摘要

相似文献

1
Extrapolating the speed of psoriasis clearance: A comparative analysis of biologic agents in clinical trials.推断银屑病清除速度：临床试验中生物制剂的比较分析。
J Am Acad Dermatol. 2024 Dec;91(6):1223-1224. doi: 10.1016/j.jaad.2024.06.103. Epub 2024 Aug 19.
2
A multinational, prospective, observational study to estimate complete skin clearance in patients with moderate-to-severe plaque PSOriasis treated with BIOlogics in a REAL world setting (PSO-BIO-REAL).一项多国前瞻性观察性研究，旨在评估在真实世界环境中接受生物制剂治疗的中度至重度斑块状银屑病患者的完全皮肤清除情况（PSO-BIO-REAL）。
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):2566-2573. doi: 10.1111/jdv.16568. Epub 2020 Jun 8.
3
Cost per cumulative clinical benefit of biologic therapies for patients with plaque psoriasis: a systematic review.生物疗法治疗斑块状银屑病患者的累积临床获益成本：系统评价。
J Manag Care Spec Pharm. 2021 Jan;27(1):84-94. doi: 10.18553/jmcp.2021.27.1.084.
4
Association Between Patient- and Physician-Reported Outcomes in Patients with Moderate-To-Severe Plaque Psoriasis Treated with Biologics in Real Life (PSO-BIO-REAL).现实生活中使用生物制剂治疗的中度至重度斑块状银屑病患者的患者报告结局与医生报告结局之间的关联（PSO-BIO-REAL）
Dermatol Ther (Heidelb). 2020 Oct;10(5):1099-1109. doi: 10.1007/s13555-020-00428-1. Epub 2020 Aug 6.
5
Cutaneous and systemic improvements in psoriasis patients after different biologic treatments in a real-world longitudinal prospective study.在一项真实世界纵向前瞻性研究中，不同生物制剂治疗后银屑病患者的皮肤及全身状况改善情况。
Sci Rep. 2025 May 3;15(1):15528. doi: 10.1038/s41598-025-99075-9.
6
Impact of previous biologic use on the efficacy and safety of brodalumab and ustekinumab in patients with moderate-to-severe plaque psoriasis: integrated analysis of the randomized controlled trials AMAGINE-2 and AMAGINE-3.在中重度斑块型银屑病患者中，既往生物制剂使用对布罗达umab 和乌司奴单抗疗效和安全性的影响：随机对照试验 AMAGINE-2 和 AMAGINE-3 的整合分析。
Br J Dermatol. 2018 Aug;179(2):320-328. doi: 10.1111/bjd.16464. Epub 2018 May 23.
7
Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab (Interleukin-23p19 Inhibitor).接受司库奇尤单抗（白细胞介素-17A拮抗剂）与古塞库单抗（白细胞介素-23p19抑制剂）治疗的中重度斑块状银屑病患者按身体部位划分的速度和累积反应
Dermatol Ther (Heidelb). 2024 Feb;14(2):441-451. doi: 10.1007/s13555-023-01075-y. Epub 2024 Feb 9.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗：一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
Complete skin clearance and Psoriasis Area and Severity Index response rates in clinical practice: predictors, health-related quality of life improvements and implications for treatment goals.临床实践中完全皮肤清除率及银屑病面积和严重程度指数反应率：预测因素、健康相关生活质量改善情况及对治疗目标的影响
Br J Dermatol. 2020 Apr;182(4):965-973. doi: 10.1111/bjd.18361. Epub 2019 Oct 16.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病：网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

引用本文的文献

1
Optimizing Psoriasis Treatment with Tildrakizumab: Current Evidence and Expert Recommendations for Treatment Individualization in Clinical Practice.使用替拉珠单抗优化银屑病治疗：临床实践中治疗个体化的当前证据和专家建议
Dermatol Ther (Heidelb). 2025 Sep 11. doi: 10.1007/s13555-025-01538-4.
2
Novel Approach for Evaluating the Effectiveness of Biological Drugs in Patients with Plaque Psoriasis: Real-World Experience of a Single-Centre Study in Poland.评估生物药物对斑块状银屑病患者有效性的新方法：波兰一项单中心研究的真实世界经验
Clin Cosmet Investig Dermatol. 2025 Jun 27;18:1615-1624. doi: 10.2147/CCID.S517656. eCollection 2025.